A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19

NCT04809389 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
115
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The University of Hong Kong